The role of anger/hostility in treatment-resistant depression: A secondary analysis from the ADAPT-A Study

Lauren B. Fisher, Maurizio Fava, Gheorghe D. Doros, Jonathan E. Alpert, Michael Henry, Ilana Huz, Marlene P. Freeman

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Major depressive disorder is often accompanied by elevated levels of anger, hostility, and irritability, which may contribute to worse outcomes. The present study is a secondary analysis examining the role of anger/hostility in the treatment response to low-dose aripiprazole added to antidepressant therapy in 225 patients with major depressive disorder and inadequate response to antidepressant treatment. Repeated-measures model demonstrated no drug-placebo difference in treatment response across levels of anger/hostility. However, withingroup analyses showed significantly lower placebo response rates in patients with high anger/hostility and a trend for lower drug response rates in patientswith high anger/hostility. Pooled response rates across phases and treatments revealed a lower response rate among patients with high anger/hostility. Depressed patients with high anger/hostility demonstrate greater illness severity and lower depressive treatment response rates than patients with low anger/hostility, suggesting that patients with high anger/hostility may have poorer outcomes in response to adjunctive treatment.

Original languageEnglish (US)
Pages (from-to)762-768
Number of pages7
JournalJournal of Nervous and Mental Disease
Volume203
Issue number10
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

Treatment-Resistant Depressive Disorder
Hostility
Anger
Major Depressive Disorder
Therapeutics
Antidepressive Agents
Placebos
Pharmaceutical Preparations

Keywords

  • Anger
  • Augmentation
  • Hostility
  • Treatment-resistant depression

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Medicine(all)

Cite this

The role of anger/hostility in treatment-resistant depression : A secondary analysis from the ADAPT-A Study. / Fisher, Lauren B.; Fava, Maurizio; Doros, Gheorghe D.; Alpert, Jonathan E.; Henry, Michael; Huz, Ilana; Freeman, Marlene P.

In: Journal of Nervous and Mental Disease, Vol. 203, No. 10, 2015, p. 762-768.

Research output: Contribution to journalArticle

Fisher, Lauren B. ; Fava, Maurizio ; Doros, Gheorghe D. ; Alpert, Jonathan E. ; Henry, Michael ; Huz, Ilana ; Freeman, Marlene P. / The role of anger/hostility in treatment-resistant depression : A secondary analysis from the ADAPT-A Study. In: Journal of Nervous and Mental Disease. 2015 ; Vol. 203, No. 10. pp. 762-768.
@article{f718b235224045a898b4972a0cf67c67,
title = "The role of anger/hostility in treatment-resistant depression: A secondary analysis from the ADAPT-A Study",
abstract = "Major depressive disorder is often accompanied by elevated levels of anger, hostility, and irritability, which may contribute to worse outcomes. The present study is a secondary analysis examining the role of anger/hostility in the treatment response to low-dose aripiprazole added to antidepressant therapy in 225 patients with major depressive disorder and inadequate response to antidepressant treatment. Repeated-measures model demonstrated no drug-placebo difference in treatment response across levels of anger/hostility. However, withingroup analyses showed significantly lower placebo response rates in patients with high anger/hostility and a trend for lower drug response rates in patientswith high anger/hostility. Pooled response rates across phases and treatments revealed a lower response rate among patients with high anger/hostility. Depressed patients with high anger/hostility demonstrate greater illness severity and lower depressive treatment response rates than patients with low anger/hostility, suggesting that patients with high anger/hostility may have poorer outcomes in response to adjunctive treatment.",
keywords = "Anger, Augmentation, Hostility, Treatment-resistant depression",
author = "Fisher, {Lauren B.} and Maurizio Fava and Doros, {Gheorghe D.} and Alpert, {Jonathan E.} and Michael Henry and Ilana Huz and Freeman, {Marlene P.}",
year = "2015",
doi = "10.1097/NMD.0000000000000364",
language = "English (US)",
volume = "203",
pages = "762--768",
journal = "Journal of Nervous and Mental Disease",
issn = "0022-3018",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - The role of anger/hostility in treatment-resistant depression

T2 - A secondary analysis from the ADAPT-A Study

AU - Fisher, Lauren B.

AU - Fava, Maurizio

AU - Doros, Gheorghe D.

AU - Alpert, Jonathan E.

AU - Henry, Michael

AU - Huz, Ilana

AU - Freeman, Marlene P.

PY - 2015

Y1 - 2015

N2 - Major depressive disorder is often accompanied by elevated levels of anger, hostility, and irritability, which may contribute to worse outcomes. The present study is a secondary analysis examining the role of anger/hostility in the treatment response to low-dose aripiprazole added to antidepressant therapy in 225 patients with major depressive disorder and inadequate response to antidepressant treatment. Repeated-measures model demonstrated no drug-placebo difference in treatment response across levels of anger/hostility. However, withingroup analyses showed significantly lower placebo response rates in patients with high anger/hostility and a trend for lower drug response rates in patientswith high anger/hostility. Pooled response rates across phases and treatments revealed a lower response rate among patients with high anger/hostility. Depressed patients with high anger/hostility demonstrate greater illness severity and lower depressive treatment response rates than patients with low anger/hostility, suggesting that patients with high anger/hostility may have poorer outcomes in response to adjunctive treatment.

AB - Major depressive disorder is often accompanied by elevated levels of anger, hostility, and irritability, which may contribute to worse outcomes. The present study is a secondary analysis examining the role of anger/hostility in the treatment response to low-dose aripiprazole added to antidepressant therapy in 225 patients with major depressive disorder and inadequate response to antidepressant treatment. Repeated-measures model demonstrated no drug-placebo difference in treatment response across levels of anger/hostility. However, withingroup analyses showed significantly lower placebo response rates in patients with high anger/hostility and a trend for lower drug response rates in patientswith high anger/hostility. Pooled response rates across phases and treatments revealed a lower response rate among patients with high anger/hostility. Depressed patients with high anger/hostility demonstrate greater illness severity and lower depressive treatment response rates than patients with low anger/hostility, suggesting that patients with high anger/hostility may have poorer outcomes in response to adjunctive treatment.

KW - Anger

KW - Augmentation

KW - Hostility

KW - Treatment-resistant depression

UR - http://www.scopus.com/inward/record.url?scp=84943393002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943393002&partnerID=8YFLogxK

U2 - 10.1097/NMD.0000000000000364

DO - 10.1097/NMD.0000000000000364

M3 - Article

C2 - 26348584

AN - SCOPUS:84943393002

VL - 203

SP - 762

EP - 768

JO - Journal of Nervous and Mental Disease

JF - Journal of Nervous and Mental Disease

SN - 0022-3018

IS - 10

ER -